CSF2 and cancer: We found that immunocompetent mice with hepatic metastasis of MC38 cancer which received AAVApoLinkerP144 showed enhanced expression of IFN-γ and GM-CSF in the metastatic nodules compared to those treated with AAVApo (Figure 2D).